7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-03

Study Completion Date

2030-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial study aims to detect the imaging characteristics of patients with hepatic encephalopathy (HE) using 7-Tesla (7T) magnetic resonance imaging (MRI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brain Diseases on 7.0T Magnetic Resonance Imaging

NCT05287750

Brain Tumor MRI Cerebrovascular Disease

RECRUITING NA

Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging

NCT01434056

End Stage Liver Disease Hepatic Encephalopathy

UNKNOWN

Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

NCT06092125

Alzheimer Disease Parkinson Disease Epilepsy +1 more

RECRUITING

Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.

NCT04942704

MRI Image Enhancement

UNKNOWN

Feasibility Testing of 7-Tesla Magnetic Resonance Imaging

NCT05992298

Magnetic Resonance Imaging

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, we analyzed the imaging characteristics of HE. First, with the advantages of 7TMRI, we analyzed the differences in imaging characteristics between HE patients and the healthy, including brain functional imaging and structural imaging. Second, we analyzed the differences in imaging characteristics between different subgroups of HE patients. Finally, we analyzed the correlation between the prognostic results of HE patients after follow-up and the imaging characteristics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatic Encephalopathy (HE) MRI fMRI Research

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

7.0T Research

With the advantages of 7.0TMRI, we detect the imaging characteristics of patients with hepatic encephalopathy (HE).

7.0T MRI-Scan

Intervention Type OTHER

7.0T MRI-Scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

7.0T MRI-Scan

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinical suspected or diagnosed hepatic encephalopathy according to relevant guidelines.The patient's education level is above primary school level.
* Regular follow-up.